These data provide evidence that ssON can ameliorate acute C48/80-dependent itch, as shown by the inhibition of C48/80-mediated pruritus but is unable to affect histamine-unrelated itch induced by the PAR2 agonist SLIGRL. Here, F2RL1 is linked to Pruritus.